Cite
HARVARD Citation
Sohn, M. et al. (2022). Cilostazol treatment for preventing adverse cardiovascular events in patients with type 2 diabetes and coronary atherosclerosis: Long‐term follow‐up of the ESCAPE study. Journal of diabetes. 14 (8), pp. 524-531. [Online].